Evidence map›Paper›PMID 41481766›Full record

ArticlePLoS pathogens2026

A prophage-encoded sRNA limits phage infection of adherent-invasive E. coli.

Nicole L Pershing, Robert S Brzozowski, Amelia K Schmidt, Dominick R Faith, Alex C Joyce, Lizett Ortiz de Ora, John D Kominsky, Annika Dankwardt, Andrew Maciver, Rickesha Bell and 7 more

Abstract read
In one paragraph

Article in PLoS pathogens, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors.

Nicole L PershingDepartment of Pediatrics, Division of Pediatric Infectious Diseases, University of Utah School of Medicine, Salt Lake City, Utah, United States of America.
Robert S BrzozowskiDivision of Biological Sciences, University of Montana, Missoula, Montana, United States of America.
Amelia K SchmidtDivision of Biological Sciences, University of Montana, Missoula, Montana, United States of America.
Dominick R FaithDepartment of Microbiology & Cell Biology, Montana State University, Bozeman, Montana, United States of America.
Alex C JoyceDepartment of Microbiology & Cell Biology, Montana State University, Bozeman, Montana, United States of America.
Lizett Ortiz de OraDepartment of Microbiology & Cell Biology, Montana State University, Bozeman, Montana, United States of America.
John D KominskyDepartment of Microbiology & Cell Biology, Montana State University, Bozeman, Montana, United States of America.
Annika DankwardtDepartment of Pediatrics, Division of Pediatric Infectious Diseases, University of Utah School of Medicine, Salt Lake City, Utah, United States of America.
Andrew MaciverDivision of Biological Sciences, University of Montana, Missoula, Montana, United States of America.
Rickesha BellOffice of Comparative Medicine, University of Utah, Salt Lake City, Utah, United States of America.
William S HenriquesDepartment of Microbiology & Cell Biology, Montana State University, Bozeman, Montana, United States of America.
Shelby E AndersenDepartment of Immunology and Microbiology, School of Medicine, University of Colorado - Anschutz Medical Campus, Aurora, Colorado, United States of America.
Blake WiedenheftDepartment of Microbiology & Cell Biology, Montana State University, Bozeman, Montana, United States of America.
Sherwood R CasjensDepartment of Pathology, Division of Microbiology and Immunology, University of Utah School of Medicine, Huntsman Cancer Institute, Salt Lake City, Utah, United States of America.
Breck A DuerkopDepartment of Immunology and Microbiology, School of Medicine, University of Colorado - Anschutz Medical Campus, Aurora, Colorado, United States of America.
June L RoundDepartment of Pathology, Division of Microbiology and Immunology, University of Utah School of Medicine, Huntsman Cancer Institute, Salt Lake City, Utah, United States of America.
Patrick R SecorDepartment of Microbiology & Cell Biology, Montana State University, Bozeman, Montana, United States of America.ORCID https://orcid.org/0000-0001-7123-3037

Funding

Research Core (Developmental Research Project Program)P20GM103474 · NIGMS · MONTANA STATE UNIVERSITY - BOZEMAN · PI MARK T QUINN · 2012 to 2026
$60.0M
CTSA UM1 Program at University of UtahUM1TR004409 · NCATS · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI RACHEL HESS, Jennifer Juhl Majersik · 2023 to 2026
$21.9M
Surveillance genome sequencing to detect SARS-CoV-2 virus variants in MontanaP30GM140963 · NIGMS · UNIVERSITY OF MONTANA · PI BOWLER, BRUCE E · 2021 to 2025
$6.9M
Antibody targeting of the viromeU01AT012990 · NCCIH · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI June Louise Round, Zac Stephens · 2024 to 2026
$5.2M
CTSA K12 Program at University of Utah: Early Career Faculty Development ProgramK12TR004413 · NCATS · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI MAUREEN A MURTAUGH, Corrine Ione Voils · 2023 to 2026
$3.9M
Structural and functional understanding of bacterial defense and viral counter defenseR35GM134867 · NIGMS · MONTANA STATE UNIVERSITY - BOZEMAN · PI Blake A Wiedenheft · 2020 to 2026
$3.8M
Bacteriophage pathobiology of inflammatory bowel diseaseR01DK124317 · NIDDK · UNIVERSITY OF UTAH · PI ROUND, JUNE LOUISE · 2020 to 2023
$2.5M
NCATS NIH HHS K12 TR004413NCATS NIH HHS UM1 TR004409NCCIH NIH HHS U01 AT012990NIDDK NIH HHS R01 DK124317NIGMS NIH HHS P20 GM103474NIGMS NIH HHS P30 GM140963NIGMS NIH HHS R35 GM134867
6 · The paper itself

Abstract

Prophages are prevalent features of bacterial genomes that can reduce susceptibility to infection by competing phages, yet the mechanisms involved are often elusive. Here, we identify a small RNA (svsR) encoded by the lambdoid prophage NC-SV in adherent-invasive Escherichia coli strain NC101 that limits infection by virulent coliphages. Comparative genomics revealed that NC-SV-like prophages and svsR homologs are broadly conserved across Enterobacteriaceae. Transcriptomic analyses show that svsR represses maltodextrin transport genes, including lamB, which encodes the outer membrane maltoporin LamB, a known receptor for numerous coliphages. Deletion of the lamB gene reveals that while LamB is not required for replication of the virulent phages tested, it contributes to plaque expansion, indicating a role in phage spread but not as an essential receptor. Nutrient supplementation experiments further linked maltodextrin and glucose availability to changes in plaque expansion and phage adsorption. In vivo, we compared wild-type NC101 and a prophage-deletion strain (NC101∆NC-SV) in mice to assess the impact of NC-SV on lytic phage susceptibility. Although intestinal E. coli densities remained stable across groups, animals colonized with NC101 exhibited markedly reduced phage burdens in both the intestinal lumen and mucosa compared to mice colonized with NC101∆NC-SV. This reduced phage pressure was associated with increased dissemination of E. coli to extraintestinal tissues, including the spleen and liver. Together, these findings highlight a nutrient-responsive, prophage-encoded mechanism that protects E. coli from phage predation and may promote bacterial persistence in and dissemination from the mammalian gut.

Indexed as

ColiphagesEscherichia coliEscherichia coli InfectionsProphagesAnimalsBacterial AdhesionMiceVirulence

Identifiers

PMID41481766
PMCPMC12803456

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.